Protocols · III
Bundle·2 compounds · save 10%
Stack III
The Metabolic Stack
Incretin / amylin co-agonism research
GLP-1 receptor agonist paired with a long-acting amylin analog — the current frontier in metabolic co-agonism research.
Stack price
Combined$0
Stack savings− $0
Total$0
+ 12% additional crypto discount at checkout
Why these together
Rationale
Semaglutide is a long-acting GLP-1 receptor agonist studied for glycemic regulation and central satiety signaling. Cagrilintide is a long-acting amylin analog studied for complementary satiety pathway activation. Their combined co-administration is an active area of metabolic and energy-expenditure research.
Compounds in this stack
- 01Semaglutide10mg · 99.6% HPLC$79.00
- 02Cagrilintide5mg · 99.0% HPLC$94.00
Recent batches
The ledger,
open.
Every batch sent for independent HPLC analysis at Janoshik Analytical. Results published the moment they land — no editorial pass, no rounding.
Compound
Purity
Batch
COA
Showing 5 of 24
Methodology→